Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v3-EN Version v1-EN
Language English English
Date Updated 2017-09-12 2017-09-11
Drug Identification Number 02437112 02437112
Brand name CEFAZOLIN FOR INJECTION CEFAZOLIN FOR INJECTION
Common or Proper name CEFAZOLIN FOR INJECTION CEFAZOLIN FOR INJECTION
Company Name HIKMA CANADA LIMITED HIKMA CANADA LIMITED
Ingredients CEFAZOLIN CEFAZOLIN
Strength(s) 1G 1G
Dosage form(s) POWDER FOR SOLUTION POWDER FOR SOLUTION
Route of administration INTRAMUSCULAR INTRAVENOUS INTRAMUSCULAR INTRAVENOUS
Packaging size PACK OF 25 VIALS PACK OF 25 VIALS
ATC code J01DB J01DB
ATC description OTHER BETA-LACTAM ANTIBACTERIALS OTHER BETA-LACTAM ANTIBACTERIALS
Reason for shortage Other (Please describe in comments) Other (Please describe in comments)
Anticipated start date
Actual start date 2017-09-11 2017-09-11
Estimated end date 2017-10-30 2017-10-30
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments Product is on allocation until October 30th, 2017 Product is on allocation until October 30th, 2017
Health Canada comments